Esperion Therapeutics Inc. (NASDAQ: ESPR) is a pharmaceutical company currently focused on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol, or LDL-C. Through the commercial execution and completion of its CLEAR Outcomes trial and the advancement of...
Shockwave Medical, Inc. (NASDAQ: SWAV) is a medical device company focused on developing products to transform how calcified cardiovascular disease is treated. Shockwave Medical, Inc. (NASDAQ: SWAV) Market Cap: $9.62B; Current Share Price: 260.83 USD Data by YCharts The Company and its Products Shockwave aims to establish a new standard...
Exagen Inc. (NASDAQ: XGN) provides autoimmune testing solutions. Exagen transforms the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen Inc. (NASDAQ: XGN) Market Cap: $36.48M; Current Share Price: 2.14 USD Data by YCharts The Company and...
Axogen, Inc. (NASDAQ: AXGN) is a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries. The Company helps to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically...
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) develops and commercializes therapeutics to improve the lives of patients with severe eye disorders. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) Market Cap: $1.02B; Current Share Price: 19.93 USD Data by YCharts The Company and its Products EyePoint’s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug...
Aytu BioPharma, Inc. (NASDAQ: AYTU) is a pharmaceutical company focused on commercializing novel therapeutics. The Company is witnessing increasing market support for its attention deficit hyperactivity disorder (ADHD) Portfolio and Pediatric Portfolio and is thus focusing its resources on these rapidly growing products. Aytu BioPharma, Inc....
Evolus, Inc. (NASDAQ: EOLS) is a performance beauty company with a customer-centric approach focused on delivering breakthrough products in the self-pay aesthetics market. This market includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for...
Pulmonx Corporation (NASDAQ: LUNG) is a global leader in minimally invasive treatments for severe lung disease. The Company’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System, and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD (chronic obstructive pulmonary disease) who,...
Zynex, Inc. (Nasdaq: ZYXI) is an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company and its Products As of December 31, 2022, the Company’s active subsidiaries are Zynex Medical, Inc. (ZMI) and Zynex Monitoring...
DocGo Inc. (NASDAQ: DCGO), a leading provider of last-mile mobile health services, is disrupting the traditional four-wall healthcare system by providing high-quality, highly affordable care to patients where and when needed. With Mobile Health, DocGo empowers the potential of telehealth by facilitating healthcare treatment, in...
